atazanavir sulfate has been researched along with Liver Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baroncelli, S; Bertolini, A; Bonora, S; Ciaffi, S; Cocchi, S; Codeluppi, M; D'Avolio, A; Di Benedetto, F; Esposito, R; Floridia, M; Guaraldi, G; Masetti, M; Motta, A; Pinetti, D | 1 |
| López-Cortés, LF | 1 |
| Antela López, A | 1 |
2 review(s) available for atazanavir sulfate and Liver Diseases
| Article | Year |
|---|---|
[Pharmacology, pharmacokinetic features and interactions of atazanavir].
Topics: Anti-HIV Agents; Atazanavir Sulfate; Biological Availability; Biotransformation; Blood Proteins; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Fetal Blood; Glucuronosyltransferase; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Infant, Newborn; Kidney Diseases; Liver Diseases; Maternal-Fetal Exchange; Metabolic Clearance Rate; Molecular Structure; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pyridines | 2008 |
[Utility of atazanavir in special populations].
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardiovascular Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Emigrants and Immigrants; Female; Heroin Dependence; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperbilirubinemia, Neonatal; Infant; Infant, Newborn; Insulin Resistance; Kidney Diseases; Liver Diseases; Male; Methadone; Multicenter Studies as Topic; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyridines; Young Adult | 2008 |
1 trial(s) available for atazanavir sulfate and Liver Diseases
| Article | Year |
|---|---|
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Area Under Curve; Atazanavir Sulfate; Female; HIV Infections; Humans; Liver Diseases; Male; Middle Aged; Oligopeptides; Pilot Projects; Pyridines; Serum | 2008 |